AstraZeneca plc (AZN) Price Target Cut to GBX 5,600 by Analysts at Deutsche Bank

AstraZeneca plc (AZN) Price Target Cut to GBX 5,600 by Analysts at Deutsche Bank


The brokerage presently has a "buy" rating on the biopharmaceutical company's stock. Deutsche Bank's price objective suggests a potential upside of 43.33% from the stock's current price.



from Biotech News